openPR Logo
Press release

Innermost Secrets Help Raise Cancer Awareness

03-29-2010 10:48 AM CET | Health & Medicine

Press release from: Innermost Secrets Ltd

/ PR Agency: Innermost Secrets Ltd
Cardiff, United Kingdom (March 19, 2010) - Innermost Secrets are distributing an Ovarian Cancer Symptom Diary to help raise awareness about Ovarian cancer in women.

Based at the Cardiff Spire Hospital, Innermost Secrets provide ultrasound and medical care for pregnant and non pregnant women at their Reproductive Health Clinic. The clinic specialises in antenatal care, specialist pregnancy ultrasound scans, fertility services including the Body Clock test to assess a woman's future fertility and sexual health advice for couples.

March 2010 is Ovarian Cancer Awareness Month and is designed to help alert women to the warning signs associated with cancer of the ovaries. Over 4,400 women die every year from ovarian cancer and it also accounts for 6% of cancer deaths in women. Based on an ultrasound scan and a blood test (CA125), Innermost Secrets can provide women with a simple annual ovarian cancer screening test which only takes thirty minutes to complete and can help detect the early signs of cancer when treatment is most effective.

To help women recognise the early warning signs of ovarian cancer, Innermost Secrets have designed and are currently distributing an Ovarian Cancer Symptom Diary to enable women to keep track of important symptoms such as stomach or pelvic pain, persistent abdominal bloating, difficulty eating and feeling full quickly etc. They can then take their completed diary to their GP should they have any concerns. The diary shows a symptom list and a daily tick chart for when the symptoms occur and their severity which will help a GP to advise whether immediate action needs to be taken.

"Ovarian cancer used to be called a silent killer but awareness of the pattern of key symptoms is an important aid to early diagnosis. The symptoms of ovarian cancer can be similar to those experienced during menstruation or irritable bowel syndrome and, as such, many women and GPs may dismiss them when in reality it could be pointing towards a significantly more serious problem," commented Dr Bryan Beattie , Director of Innermost Secrets. "We have constructed this diary to help women keep track of their symptoms over a 4 week period which can help GPs quickly identify any pattern and thus significance . There is an ideal opportunity this month for the media to raise awareness of ovarian cancer and we hope that our diary can play a part in that."

To find out more about Innermost Secrets and the services offered by their ovarian cancer screening clinic, fertility clinic and other clinics, visit their website at http://www.innermostsecrets.com or telephone 0345 230 3386 during office hours.

Based at he Spire Cardiff Hospital, Innermost Secrets are a consortium of consultants and specialists who provide a range of clinics and services such as a fertility clinic, recurrent miscarriage clinic, pregnancy scans, antenatal care, private parentcraft classes and pregnancy advice for both men and women. Providing accurate information, quality medical care and support . They can provide important information to help men and women make qualified, informed decisions about their future reproductive health choices, and have qualified experts in the fields of fertility, sexual health, obstetrics and fetal and maternal medicine to support them in those choices.

Innermost Secrets Ltd
Unit 3 above Alliance Cars
Pentwyn Business Centre
Wharfedale Road
Cardiff
CF23 7HB
0345 230 3386

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Innermost Secrets Help Raise Cancer Awareness here

News-ID: 125078 • Views: 788

More Releases from Innermost Secrets Ltd

Innermost Secrets Offer Specific Recurrent Miscarriage Tests
Cardiff, United Kingdom (January 28, 2011) – Innermost Secrets, a leading Cardiff based fertility clinic, is one of the first clinics in the UK to offer a specific tests for women who have suffered recurrent miscarriages. Recurrent miscarriage is a condition which affects about 2-3% of women and causes repeated heartache and trauma for many women, their partners and their families. Traditionally, women with 3 or more miscarriages would be offered
Innermost Secrets Hold Educational Symposium
Cardiff, United Kingdom (12 November 2010) - Innermost Secrets, a leading fertility clinic, provide an educational symposium for patients and medical professionals. Cardiff-based private fertility clinic, Innermost Secrets, was the first in the UK to launch a service for pregnant women at risk of premature birth and late miscarriage earlier in 2010. In 2011 they will be raising awareness of being ‘Born Too Soon’ with an educational symposium for patients and
Innermost Secrets Host Two Day Medical Conference
Cardiff, United Kingdom (12 November 2010) – A Cardiff based non-profit making educational organization, Innermost Learning, have recently hosted a two day conference for medical professionals on how to mend babies’ broken hearts, and how to find out if and how they got broken in the first place. The conference was organised by local specialists in paediatric cardiology, fetal medicine and obstetrics and the two day event included groundbreaking work

All 4 Releases


More Releases for Ovarian

Polycystic Ovarian Syndrome Treatment Market - Regional Analysis
The organic and inorganic strategies by the market players will boost the polycystic ovarian syndrome treatment market. For instance, in 2016, Millendo Therapeutics, Inc., a biopharmaceutical company, entered into an exclusive license agreement with AstraZeneca for the development and commercialization of phase II entered AZD4901, a candidate product for the treatment of polycystic ovarian syndrome. Moreover, in 2017, Astellas Pharma Inc. completed its acquisition of Ogeda SA (formerly Euroscreen S.A.).
Polycystic Ovarian Syndrome - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Polycystic Ovarian Syndrome - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Ovarian Syndrome - Pipeline Review, H2 2017, provides an overview of the Polycystic Ovarian Syndrome (Women's Health) pipeline landscape. Polycystic ovary syndrome (PCOS) is a common hormonal disorder among women of reproductive age. Symptoms
Ovarian Cancer Drugs Market Report : 2017
Reports And Markets Publish a New Market Research Report On –"Ovarian Cancer Drugs Market Report : 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/united-states-ovarian-cancer-drugs-market-report-2017-1541150 In this report, the United States Ovarian Cancer Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United
Ovarian Cancer - Pipeline Review, H1 2017
Report Hive Market Research Released a New Research Report of 2027 pages on Title " Ovarian Cancer - Pipeline Review, H1 2017 "with detailed Analysis, Forecast and Strategies. Ovarian Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Pipeline Review, H1 2017, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape. Ovarian cancer is any cancerous growth that may occur in different
Ovarian Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Ovarian Cancer - Heat Map and Analysis to its growing collection of premium market research reports. Ovarian Cancer (OC) is the fifth most common malignancy diagnosed in women, and the most common gynecological cancer, with an estimated 225,000 new cases diagnosed globally in 2008. Rates are particularly high in developed countries, and especially in Northern Europe. However, substantial improvements in
Latest Report: Global Ovarian Cancer Market 2017
MarketResearchReports.Biz presents this most up-to-date research on "Ovarian Cancer - Treatment Landscape & Competitive Analysis, 2017" DelveInsights, Ovarian Cancer - Treatment Landscape & Competitive Analysis, 2017, report provides comprehensive insights about the treatment landscape across this indication. This report also provides the deep understanding of the stages of the ovarian cancer, epidemiology, risk factors, diagnosis etc. A key objective of the report is to establish the understanding of the treatment landscape